HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Eugenia Socías Selected Research

M Eugenia Socías Research Topics

Disease

11Opioid-Related Disorders (Opiate Addiction)
05/2024 - 12/2016
3Pain (Aches)
11/2023 - 01/2020
2Chronic Pain
11/2023 - 01/2021
2Opiate Overdose
01/2021 - 01/2021
2Hepatitis C
01/2019 - 11/2015
2HIV Infections (HIV Infection)
01/2019 - 09/2017
1Frailty
01/2023
1COVID-19
12/2020
1Nausea
01/2020
1Sleep Initiation and Maintenance Disorders (Insomnia)
01/2020
1Infections
01/2019
1Sexually Transmitted Diseases (Sexually Transmitted Disease)
06/2017
1Disease Progression
08/2011

Drug/Important Bio-Agent (IBA)

7Opioid Analgesics (Opioids)IBA
05/2024 - 12/2016
5Methadone (Dolophine)FDA LinkGeneric
05/2024 - 01/2019
2Naloxone Drug Combination BuprenorphineFDA Link
05/2024 - 01/2020
2Buprenorphine (Subutex)FDA LinkGeneric
01/2024 - 01/2020
2Fentanyl (Sublimaze)FDA LinkGeneric
01/2024 - 01/2021
22-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA
01/2023 - 01/2023
2Illicit Drugs (Recreational Drugs)IBA
11/2021 - 12/2020
2Morphine (MS Contin)FDA LinkGeneric
01/2019 - 01/2018
1Amphetamine (Amfetamine)FDA LinkGeneric
05/2024
1Methamphetamine (Desoxyn)FDA LinkGeneric
05/2024
1Therapeutic UsesIBA
01/2020
1InterferonsIBA
01/2019
1Antiviral Agents (Antivirals)IBA
01/2019
1Reverse Transcriptase InhibitorsIBA
09/2017
1N,N-dimethyl-4-anisidine (DMPA)IBA
06/2017

Therapy/Procedure

5Therapeutics
05/2024 - 12/2016
2Injections
01/2024 - 01/2021
1Time-to-Treatment
01/2023
1Retention in Care
01/2021
1Pain Management
01/2020
1Continuity of Patient Care
11/2015
1Highly Active Antiretroviral Therapy (HAART)
08/2011